Sonoma Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Sonoma Pharmaceuticals Stock Summary

Sonoma Pharmaceuticals competes with China Pharma, Universe Pharmaceuticals, Akanda Corp, Petros Pharmaceuticals, and Sunshine Biopharma. Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Woodstock, Georgia. Sonoma Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.

Sonoma Pharmaceuticals Key Financial Ratios

Sonoma Pharmaceuticals Key Balance Sheet Accounts

Sonoma Pharmaceuticals Key Income Statement Accounts

Sonoma Pharmaceuticals Key Cash Accounts

Sonoma Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Sonoma Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Sonoma Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sonoma Pharmaceuticals competition to find correlations between indicators driving Sonoma Pharmaceuticals's intrinsic value. More Info.Sonoma Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Sonoma Pharmaceuticals' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sonoma Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Sonoma Pharmaceuticals' Earnings Breakdown by Geography

Sonoma Pharmaceuticals Systematic Risk

Today, most investors in Sonoma Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sonoma Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Sonoma Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Sonoma Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sonoma Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sonoma Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Sonoma Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sonoma Pharmaceuticals's daily price indicators and compare them against related drivers.

When running Sonoma Pharmaceuticals' price analysis, check to measure Sonoma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonoma Pharmaceuticals is operating at the current time. Most of Sonoma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Sonoma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonoma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Sonoma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.